{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:39:03Z","timestamp":1778809143203,"version":"3.51.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T00:00:00Z","timestamp":1426550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2015.20","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T14:51:49Z","timestamp":1426603909000},"page":"e531-e531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence"],"prefix":"10.1038","volume":"5","author":[{"given":"A-L","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Elman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S B","family":"Lowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S J","family":"Blady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K G","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Hyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C P","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D D","family":"Langleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,17]]},"reference":[{"key":"BFtp201520_CR1","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1001\/jama.2011.369","volume":"305","author":"ND Volkow","year":"2011","unstructured":"Volkow ND, McLellan TA . Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA 2011; 305: 1346\u20131347.","journal-title":"JAMA"},{"key":"BFtp201520_CR2","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMp1402780","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Frieden TR, Hyde PS, Cha SS . Medication-assisted therapies\u2014tackling the opioid-overdose epidemic. N Engl J Med 2014; 370: 2063\u20132066.","journal-title":"N Engl J Med"},{"key":"BFtp201520_CR3","unstructured":"SAMHSA. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings Substance Abuse and Mental Health Services Administration: Rockville, MD, USA, 2013."},{"key":"BFtp201520_CR4","unstructured":"NIDA. Heroin. In: Research Report Series. National Institutes of Health: Bethesda, MD, USA, 2014."},{"key":"BFtp201520_CR5","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095\u20132128.","journal-title":"Lancet"},{"key":"BFtp201520_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2008.976","volume":"301","author":"RK Chandler","year":"2009","unstructured":"Chandler RK, Fletcher BW, Volkow ND . Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA 2009; 301: 183\u2013190.","journal-title":"JAMA"},{"key":"BFtp201520_CR7","unstructured":"National Institute on Drug Abuse.. Drug Facts: Treatment Statistics. 2011; http:\/\/www.drugabuse.gov\/publications\/drugfacts\/treatment-statistics; accessed on 20 December 2014."},{"key":"BFtp201520_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jsm.12352","volume":"11","author":"A Yee","year":"2014","unstructured":"Yee A, Loh HS, Hisham Hashim HM, Ng CG . The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study. J Sex Med 2014; 11: 22\u201332.","journal-title":"J Sex Med"},{"key":"BFtp201520_CR9","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1001\/archinte.166.12.1280","volume":"166","author":"GB Ehret","year":"2006","unstructured":"Ehret GB, Voide C, Gex-Fabry M, Chabert J, Shah D, Broers B et al. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Arch Intern Med 2006; 166: 1280\u20131287.","journal-title":"Arch Intern Med"},{"key":"BFtp201520_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4065\/mcp.2010.0575","volume":"86","author":"MT Brown","year":"2011","unstructured":"Brown MT, Bussell JK . Medication adherence: WHO cares? Mayo Clin Proc 2011; 86: 304\u2013314.","journal-title":"Mayo Clin Proc"},{"key":"BFtp201520_CR11","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.15288\/jsad.2011.72.1012","volume":"72","author":"R Swift","year":"2011","unstructured":"Swift R, Oslin DW, Alexander M, Forman R . Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. J Stud Alcohol Drugs 2011; 72: 1012\u20131018.","journal-title":"J Stud Alcohol Drugs"},{"key":"BFtp201520_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.drugalcdep.2007.06.013","volume":"91","author":"MA Sullivan","year":"2007","unstructured":"Sullivan MA, Garawi F, Bisaga A, Comer SD, Carpenter K, Raby WN et al. Management of relapse in naltrexone maintenance for heroin dependence. Drug Alcohol Depend 2007; 91: 289\u2013292.","journal-title":"Drug Alcohol Depend"},{"key":"BFtp201520_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2013.05.030","volume":"133","author":"MA Sullivan","year":"2013","unstructured":"Sullivan MA, Bisaga A, Mariani JJ, Glass A, Levin FR, Comer SD et al. Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade? Drug Alcohol Depend 2013; 133: 80\u201385.","journal-title":"Drug Alcohol Depend"},{"key":"BFtp201520_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cct.2013.12.006","volume":"37","author":"SA Springer","year":"2014","unstructured":"Springer SA, Altice FL, Herme M, Di Paola A . Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community. Contemp Clin Trials 2014; 37: 209\u2013218.","journal-title":"Contemp Clin Trials"},{"key":"BFtp201520_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/08897077.2012.763083","volume":"34","author":"PD Friedmann","year":"2013","unstructured":"Friedmann PD, Mello D, Lonergan S, Bourgault C, O'Toole TP . Aversion to injection limits acceptability of extended-release naltrexone among homeless, alcohol-dependent patients. Subst Abus 2013; 34: 94\u201396.","journal-title":"Subst Abus"},{"key":"BFtp201520_CR16","doi-asserted-by":"publisher","first-page":"e1056","DOI":"10.4088\/JCP.09m05807","volume":"73","author":"WM Aklin","year":"2012","unstructured":"Aklin WM, Severtson SG, Umbricht A, Fingerhood M, Bigelow GE, Lejuez CW et al. Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence. J Clin Psychiatry 2012; 73: e1056\u2013e1061.","journal-title":"J Clin Psychiatry"},{"key":"BFtp201520_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1530-0277.2008.00846.x","volume":"33","author":"G Oroszi","year":"2009","unstructured":"Oroszi G, Anton RF, O'Malley S, Swift R, Pettinati H, Couper D et al. OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin Exp Res 2009; 33: 383\u2013393.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFtp201520_CR18","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1046\/j.1360-0443.95.8s2.7.x","volume":"95","author":"ST Tiffany","year":"2000","unstructured":"Tiffany ST, Carter BL, Singleton EG . Challenges in the manipulation, assessment and interpretation of craving relevant variables. Addiction 2000; 95: S177\u2013S187.","journal-title":"Addiction"},{"key":"BFtp201520_CR19","first-page":"495","volume":"56","author":"HP Jhingan","year":"2002","unstructured":"Jhingan HP, Jain R, Desai NG, Vaswani M, Tripathi BM, Pandey RM . Validity of self-report of recent opiate use in treatment setting. Indian J Med Sci 2002; 56: 495\u2013500.","journal-title":"Indian J Med Sci"},{"key":"BFtp201520_CR20","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.addbeh.2006.02.015","volume":"31","author":"WJ Chen","year":"2006","unstructured":"Chen WJ, Fang CC, Shyu RS, Lin KC . Underreporting of illicit drug use by patients at emergency departments as revealed by two-tiered urinalysis. Addict Behav 2006; 31: 2304\u20132308.","journal-title":"Addict Behav"},{"key":"BFtp201520_CR21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.eurpsy.2007.05.001","volume":"22","author":"R de Beaurepaire","year":"2007","unstructured":"de Beaurepaire R, Lukasiewicz M, Beauverie P, Castera S, Dagorne O, Espaze R et al. Comparison of self-reports and biological measures for alcohol, tobacco, and illicit drugs consumption in psychiatric inpatients. Eur Psychiatry 2007; 22: 540\u2013548.","journal-title":"Eur Psychiatry"},{"key":"BFtp201520_CR22","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.addbeh.2006.06.034","volume":"32","author":"UE Ghitza","year":"2007","unstructured":"Ghitza UE, Epstein DH, Preston KL . Nonreporting of cannabis use: predictors and relationship to treatment outcome in methadone maintained patients. Addict Behav 2007; 32: 938\u2013949.","journal-title":"Addict Behav"},{"key":"BFtp201520_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1369-1600.2012.00462.x","volume":"19","author":"DD Langleben","year":"2014","unstructured":"Langleben DD, Ruparel K, Elman I, Loughead JW, Busch EL, Cornish J et al. Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients. Addict Biol 2014; 19: 262\u2013271.","journal-title":"Addict Biol"},{"key":"BFtp201520_CR24","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.1523\/JNEUROSCI.0005-12.2012","volume":"32","author":"JM Bossert","year":"2012","unstructured":"Bossert JM, Stern AL, Theberge FR, Marchant NJ, Wang HL, Morales M et al. Role of projections from ventral medial prefrontal cortex to nucleus accumbens shell in context-induced reinstatement of heroin seeking. J Neurosci 2012; 32: 4982\u20134991.","journal-title":"J Neurosci"},{"key":"BFtp201520_CR25","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrn3119","volume":"12","author":"RZ Goldstein","year":"2011","unstructured":"Goldstein RZ, Volkow ND . Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 2011; 12: 652\u2013669.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp201520_CR26","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1176\/appi.ajp.159.10.1642","volume":"159","author":"RZ Goldstein","year":"2002","unstructured":"Goldstein RZ, Volkow ND . Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159: 1642\u20131652.","journal-title":"Am J Psychiatry"},{"key":"BFtp201520_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nn.2761","volume":"14","author":"HF Chua","year":"2011","unstructured":"Chua HF, Ho SS, Jasinska AJ, Polk TA, Welsh RC, Liberzon I et al. Self-related neural response to tailored smoking-cessation messages predicts quitting. Nat Neurosci 2011; 14: 426\u2013427.","journal-title":"Nat Neurosci"},{"key":"BFtp201520_CR28","unstructured":"First M (ed). Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision American Psychiatric Association: Washington, DC, USA, 2002."},{"key":"BFtp201520_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","volume":"9","author":"AT McLellan","year":"1992","unstructured":"McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9: 199\u2013213.","journal-title":"J Subst Abuse Treat"},{"key":"BFtp201520_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0028-3932(71)90067-4","volume":"9","author":"RC Oldfield","year":"1971","unstructured":"Oldfield RC . The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9: 97\u2013113.","journal-title":"Neuropsychologia"},{"key":"BFtp201520_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5055\/jom.2010.0028","volume":"6","author":"X Ruan","year":"2010","unstructured":"Ruan X, Chen T, Gudin J, Couch JP, Chiravuri S . Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature. J Opioid Manag 2010; 6: 300\u2013303.","journal-title":"J Opioid Manag"},{"key":"BFtp201520_CR32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1124\/jpet.110.173823","volume":"336","author":"CA Paronis","year":"2011","unstructured":"Paronis CA, Bergman J . Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal. J Pharmacol Exp Ther 2011; 336: 488\u2013495.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp201520_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0376-8716(00)00139-3","volume":"61","author":"I Elman","year":"2001","unstructured":"Elman I, D'Ambra MN, Krause S, Breiter H, Kane M, Morris R et al. Ultrarapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes. Drug Alcohol Depend 2001; 61: 163\u2013172.","journal-title":"Drug Alcohol Depend"},{"key":"BFtp201520_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/jat\/31.8.453","volume":"31","author":"MH Slawson","year":"2007","unstructured":"Slawson MH, Chen M, Moody D, Comer SD, Nuwayser ES, Fang WB et al. Quantitative analysis of naltrexone and 6beta-naltrexol in human, rat, and rabbit plasma by liquid chromatography-electrospray ionization tandem mass spectrometry with application to the pharmacokinetics of Depotrex in rabbits. J Anal Toxicol 2007; 31: 453\u2013461.","journal-title":"J Anal Toxicol"},{"key":"BFtp201520_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1176\/appi.ajp.2007.07010070","volume":"165","author":"DD Langleben","year":"2008","unstructured":"Langleben DD, Ruparel K, Elman I, Busch-Winokur S, Pratiwadi R, Loughead J et al. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry 2008; 165: 390\u2013394.","journal-title":"Am J Psychiatry"},{"key":"BFtp201520_CR36","first-page":"73","volume":"137","author":"AR Childress","year":"1993","unstructured":"Childress AR, Hole AV, Ehrman RN, Robbins SJ, McLellan AT, O'Brien CP . Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr 1993; 137: 73\u201395.","journal-title":"NIDA Res Monogr"},{"key":"BFtp201520_CR37","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/mrm.1910250220","volume":"25","author":"PA Bandettini","year":"1992","unstructured":"Bandettini PA, Wong EC, Hinks RS, Tikofsky RS, Hyde JS . Time course EPI of human brain function during task activation. Magn Reson Med 1992; 25: 390\u2013397.","journal-title":"Magn Reson Med"},{"key":"BFtp201520_CR38","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1073\/pnas.89.12.5675","volume":"89","author":"KK Kwong","year":"1992","unstructured":"Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 1992; 89: 5675\u20135679.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp201520_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8","volume":"10","author":"JL Lancaster","year":"2000","unstructured":"Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000; 10: 120\u2013131.","journal-title":"Hum Brain Mapp"},{"key":"BFtp201520_CR40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","volume":"63","author":"SD Comer","year":"2006","unstructured":"Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K et al. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2006; 63: 210\u2013218.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp201520_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.drugalcdep.2011.12.022","volume":"124","author":"DA Nielsen","year":"2012","unstructured":"Nielsen DA, Ho A, Bahl A, Varma P, Kellogg S, Borg L et al. Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls. Drug Alcohol Depend 2012; 124: 113\u2013120.","journal-title":"Drug Alcohol Depend"},{"key":"BFtp201520_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1300\/J069v26n01_08","volume":"26","author":"I Maremmani","year":"2007","unstructured":"Maremmani I, Pani PP, Mellini A, Pacini M, Marini G, Lovrecic M et al. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program. J Addict Dis 2007; 26: 61\u201370.","journal-title":"J Addict Dis"},{"key":"BFtp201520_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hbm.10062","volume":"17","author":"SM Smith","year":"2002","unstructured":"Smith SM . Fast robust automated brain extraction. Hum Brain Mapp 2002; 17: 143\u2013155.","journal-title":"Hum Brain Mapp"},{"key":"BFtp201520_CR44","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1006\/nimg.2002.1132","volume":"17","author":"M Jenkinson","year":"2002","unstructured":"Jenkinson M, Bannister P, Brady M, Smith S . Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002; 17: 825\u2013841.","journal-title":"Neuroimage"},{"key":"BFtp201520_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","volume":"5","author":"M Jenkinson","year":"2001","unstructured":"Jenkinson M, Smith S . A global optimisation method for robust affine registration of brain images. Med Image Anal 2001; 5: 143\u2013156.","journal-title":"Med Image Anal"},{"key":"BFtp201520_CR46","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1006\/nimg.2001.0931","volume":"14","author":"MW Woolrich","year":"2001","unstructured":"Woolrich MW, Ripley BD, Brady M, Smith SM . Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 2001; 14: 1370\u20131386.","journal-title":"Neuroimage"},{"key":"BFtp201520_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1109\/TMI.2003.822821","volume":"23","author":"CF Beckmann","year":"2004","unstructured":"Beckmann CF, Smith SM . Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging 2004; 23: 137\u2013152.","journal-title":"IEEE Trans Med Imaging"},{"key":"BFtp201520_CR48","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/mrm.1910330508","volume":"33","author":"SD Forman","year":"1995","unstructured":"Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC . Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med 1995; 33: 636\u2013647.","journal-title":"Magn Reson Med"},{"key":"BFtp201520_CR49","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00234-012-1056-2","volume":"54","author":"D Zaca","year":"2012","unstructured":"Zaca D, Nickerson JP, Deib G, Pillai JJ . Effectiveness of four different clinical fMRI paradigms for preoperative regional determination of language lateralization in patients with brain tumors. Neuroradiology 2012; 54: 1015\u20131025.","journal-title":"Neuroradiology"},{"key":"BFtp201520_CR50","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1007\/s00330-011-2184-5","volume":"21","author":"T Auer","year":"2011","unstructured":"Auer T, Schweizer R, Frahm J . An iterative two-threshold analysis for single-subject functional MRI of the human brain. Eur Radiol 2011; 21: 2369\u20132387.","journal-title":"Eur Radiol"},{"key":"BFtp201520_CR51","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.yebeh.2009.07.034","volume":"16","author":"RO Suarez","year":"2009","unstructured":"Suarez RO, Whalen S, Nelson AP, Tie Y, Meadows ME, Radmanesh A et al. Threshold-independent functional MRI determination of language dominance: a validation study against clinical gold standards. Epilepsy Behav 2009; 16: 288\u2013297.","journal-title":"Epilepsy Behav"},{"key":"BFtp201520_CR52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/scan\/nsp052","volume":"4","author":"MD Lieberman","year":"2009","unstructured":"Lieberman MD, Cunningham WA . Type I and Type II error concerns in fMRI research: re-balancing the scale. Soc Cogn Affect Neurosci 2009; 4: 423\u2013428.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"BFtp201520_CR53","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1191\/0962280203sm340ra","volume":"12","author":"KJ Worsley","year":"2003","unstructured":"Worsley KJ . Detecting activation in fMRI data. Stat Methods Med Res 2003; 12: 401\u2013418.","journal-title":"Stat Methods Med Res"},{"key":"BFtp201520_CR54","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/nimg.1996.0074","volume":"4","author":"KJ Friston","year":"1996","unstructured":"Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD . Detecting activations in PET and fMRI: levels of inference and power. Neuroimage 1996; 4: 223\u2013235.","journal-title":"Neuroimage"},{"key":"BFtp201520_CR55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00213-011-2503-1","volume":"220","author":"DD Langleben","year":"2012","unstructured":"Langleben DD, Busch EL, O'Brien CP, Elman I . Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence. Psychopharmacology (Berl) 2012; 220: 559\u2013564.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201520_CR56","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","volume":"377","author":"E Krupitsky","year":"2011","unstructured":"Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL . Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet 2011; 377: 1506\u20131513.","journal-title":"Lancet"},{"key":"BFtp201520_CR57","first-page":"106","volume":"20","author":"CP O'Brien","year":"2011","unstructured":"O'Brien CP, Gastfriend DR, Forman RF, Schweizer E, Pettinati HM . Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone. Am J Addict 2011; 20: 106\u2013112.","journal-title":"Am J Addict"},{"key":"BFtp201520_CR58","doi-asserted-by":"crossref","unstructured":"Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A . Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev 2011; CD001333.","DOI":"10.1002\/14651858.CD001333.pub4"},{"key":"BFtp201520_CR59","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1192\/bjp.195.52.s37","volume":"52","author":"TR Barnes","year":"2009","unstructured":"Barnes TR, Shingleton-Smith A, Paton C . Antipsychotic long-acting injections: prescribing practice in the UK. Br J Psychiatry Suppl 2009; 52: S37\u2013S42.","journal-title":"Br J Psychiatry Suppl"},{"key":"BFtp201520_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/acem.12286","volume":"21","author":"LN Maslov","year":"2014","unstructured":"Maslov LN, Oeltgen PR, Lishmanov YB, Brown SA, Barzakh EI, Krylatov AV et al. Activation of peripheral delta opioid receptors increases cardiac tolerance to arrhythmogenic effect of ischemia\/reperfusion. Acad Emerg Med 2014; 21: 31\u201339.","journal-title":"Acad Emerg Med"},{"key":"BFtp201520_CR61","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1523\/JNEUROSCI.3446-12.2013","volume":"33","author":"DG Gee","year":"2013","unstructured":"Gee DG, Humphreys KL, Flannery J, Goff B, Telzer EH, Shapiro M et al. A developmental shift from positive to negative connectivity in human amygdala-prefrontal circuitry. J Neurosci 2013; 33: 4584\u20134593.","journal-title":"J Neurosci"},{"key":"BFtp201520_CR62","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.neuroimage.2011.01.027","volume":"55","author":"P Sagaspe","year":"2011","unstructured":"Sagaspe P, Schwartz S, Vuilleumier P . Fear and stop: a role for the amygdala in motor inhibition by emotional signals. Neuroimage 2011; 55: 1825\u20131835.","journal-title":"Neuroimage"},{"key":"BFtp201520_CR63","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/hbm.20208","volume":"27","author":"LM Williams","year":"2006","unstructured":"Williams LM, Liddell BJ, Kemp AH, Bryant RA, Meares RA, Peduto AS et al. Amygdala-prefrontal dissociation of subliminal and supraliminal fear. Hum Brain Mapp 2006; 27: 652\u2013661.","journal-title":"Hum Brain Mapp"},{"key":"BFtp201520_CR64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fnbeh.2012.00050","volume":"6","author":"AJ Gruber","year":"2012","unstructured":"Gruber AJ, McDonald RJ . Context, emotion, and the strategic pursuit of goals: interactions among multiple brain systems controlling motivated behavior. Front Behav Neurosci 2012; 6: 50.","journal-title":"Front Behav Neurosci"},{"key":"BFtp201520_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.brainres.2009.03.038","volume":"1293","author":"GF Koob","year":"2009","unstructured":"Koob GF . Brain stress systems in the amygdala and addiction. Brain Res 2009; 1293: 61\u201375.","journal-title":"Brain Res"},{"key":"BFtp201520_CR66","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.neuron.2004.08.042","volume":"43","author":"EA Phelps","year":"2004","unstructured":"Phelps EA, Delgado MR, Nearing KI, LeDoux JE . Extinction learning in humans: role of the amygdala and vmPFC. Neuron 2004; 43: 897\u2013905.","journal-title":"Neuron"},{"key":"BFtp201520_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.06.003","volume":"109","author":"I Elman","year":"2013","unstructured":"Elman I, Borsook D, Volkow ND . Pain and suicidality: insights from reward and addiction neuroscience. Prog Neurobiol 2013; 109: 1\u201327.","journal-title":"Prog Neurobiol"},{"key":"BFtp201520_CR68","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejphar.2007.09.042","volume":"579","author":"J Shi","year":"2008","unstructured":"Shi J, Zhao LY, Copersino ML, Fang YX, Chen Y, Tian J et al. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol 2008; 579: 160\u2013166.","journal-title":"Eur J Pharmacol"},{"key":"BFtp201520_CR69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fpubh.2013.00061","volume":"1","author":"LH Quek","year":"2013","unstructured":"Quek LH, Chan GC, White A, Connor JP, Baker PJ, Saunders JB et al. Concurrent and simultaneous polydrug use: latent class analysis of an Australian nationally representative sample of young adults. Front Public Health 2013; 1: 61.","journal-title":"Front Public Health"},{"key":"BFtp201520_CR70","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","volume":"58","author":"YI Hser","year":"2001","unstructured":"Hser YI, Hoffman V, Grella CE, Anglin MD . A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001; 58: 503\u2013508.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp201520_CR71","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.lfs.2013.07.018","volume":"93","author":"LN Maslov","year":"2013","unstructured":"Maslov LN, Naryzhnaia NV, Tsibulnikov SY, Kolar F, Zhang Y, Wang H et al. Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia. Life Sci 2013; 93: 373\u2013379.","journal-title":"Life Sci"},{"key":"BFtp201520_CR72","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/emj.19.3.264","volume":"19","author":"B McCann","year":"2002","unstructured":"McCann B, Hunter R, McCann J . Cocaine\/heroin induced rhabdomyolysis and ventricular fibrillation. Emerg Med J 2002; 19: 264\u2013265.","journal-title":"Emerg Med J"},{"key":"BFtp201520_CR73","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/15563659609013811","volume":"34","author":"JJ Osterwalder","year":"1996","unstructured":"Osterwalder JJ . Naloxone\u2014for intoxications with intravenous heroin and heroin mixtures\u2014harmless or hazardous? A prospective clinical study. J Toxicol Clin Toxicol 1996; 34: 409\u2013416.","journal-title":"J Toxicol Clin Toxicol"},{"key":"BFtp201520_CR74","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0735-6757(93)90074-L","volume":"11","author":"KS Merigian","year":"1993","unstructured":"Merigian KS . Cocaine-induced ventricular arrhythmias and rapid atrial fibrillation temporally related to naloxone administration. Am J Emerg Med 1993; 11: 96\u201397.","journal-title":"Am J Emerg Med"},{"key":"BFtp201520_CR75","doi-asserted-by":"publisher","first-page":"e004393","DOI":"10.1136\/bmjopen-2013-004393","volume":"4","author":"SP David","year":"2014","unstructured":"David SP, Chu IM, Lancaster T, Stead LF, Evins AE, Prochaska JJ . Systematic review and meta-analysis of opioid antagonists for smoking cessation. BMJ Open 2014; 4: e004393.","journal-title":"BMJ Open"},{"key":"BFtp201520_CR76","doi-asserted-by":"crossref","unstructured":"Mannelli P, Wu LT, Peindl KS, Gorelick DA . Smoking and opioid detoxification: behavioral changes and response to treatment. Nicotine Tob Res 2013.","DOI":"10.1093\/ntr\/ntt046"},{"key":"BFtp201520_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1874473711306010009","volume":"6","author":"A Zirakzadeh","year":"2013","unstructured":"Zirakzadeh A, Shuman C, Stauter E, Hays JT, Ebbert JO . Cigarette smoking in methadone maintained patients: an up-to-date review. Curr Drug Abuse Rev 2013; 6: 77\u201384.","journal-title":"Curr Drug Abuse Rev"},{"key":"BFtp201520_CR78","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.neuropharm.2010.11.010","volume":"60","author":"M Hadjiconstantinou","year":"2011","unstructured":"Hadjiconstantinou M, Neff NH . Nicotine and endogenous opioids: neurochemical and pharmacological evidence. Neuropharmacology 2011; 60: 1209\u20131220.","journal-title":"Neuropharmacology"},{"key":"BFtp201520_CR79","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/adb.12022","volume":"19","author":"EM Weerts","year":"2012","unstructured":"Weerts EM, Wand GS, Kuwabara H, Xu X, Frost JJ, Wong DF et al. Association of smoking with mu-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects. Addict Biol 2012; 19: 733\u2013742.","journal-title":"Addict Biol"},{"key":"BFtp201520_CR80","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3390\/ijerph9030932","volume":"9","author":"B Pajusco","year":"2012","unstructured":"Pajusco B, Chiamulera C, Quaglio G, Moro L, Casari R, Amen G et al. Tobacco addiction and smoking status in heroin addicts under methadone vs buprenorphine therapy. Int J Environ Res Public Health 2012; 9: 932\u2013942.","journal-title":"Int J Environ Res Public Health"},{"key":"BFtp201520_CR81","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00213-012-2801-2","volume":"225","author":"KM Seip-Cammack","year":"2013","unstructured":"Seip-Cammack KM, Reed B, Zhang Y, Ho A, Kreek MJ . Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors. Psychopharmacology (Berl) 2013; 225: 127\u2013140.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201520_CR82","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMsa1405092","volume":"371","author":"ER Kandel","year":"2014","unstructured":"Kandel ER, Kandel DB . Shattuck Lecture. A molecular basis for nicotine as a gateway drug. N Engl J Med 2014; 371: 932\u2013943.","journal-title":"N Engl J Med"},{"key":"BFtp201520_CR83","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1037\/1064-1297.15.2.134","volume":"15","author":"SM Hyman","year":"2007","unstructured":"Hyman SM, Fox H, Hong KI, Doebrick C, Sinha R . Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment. Exp Clin Psychopharmacol 2007; 15: 134\u2013143.","journal-title":"Exp Clin Psychopharmacol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp201520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201520","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T09:43:15Z","timestamp":1672911795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp201520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,17]]},"references-count":83,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3]]}},"alternative-id":["BFtp201520"],"URL":"https:\/\/doi.org\/10.1038\/tp.2015.20","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,17]]},"assertion":[{"value":"5 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CPO'B served as a consultant to Alkermes plc and Tekmira Pharmaceuticals. The remaining authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}